The rising prevalence in GLP-1 agonists for diabetes has led to a question about delivery methods : transdermal systems versus tablets . Typically, GLP-1 treatments were solely available in oral form, https://steveskcd093884.mybuzzblog.com/21043124/glp-1-transdermal-delivery-systems-vs-tablets-which-suitable-for-individuals